Sudeep Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1,146	368.07	139.76	103.01	214.74
Short-Term Investments	-	150	-	-	-
Trading Asset Securities	-	1.36	1.27	30.33	-
Cash & Short-Term Investments	1,146	519.43	141.03	133.34	214.74
Cash Growth	120.71%	268.32%	5.77%	-37.91%	654176.23%
Accounts Receivable	2,275	1,854	1,446	937.12	1,066
Other Receivables	-	313.39	231.64	320.71	111.51
Receivables	2,278	2,170	1,690	1,268	1,185
Inventory	2,160	1,287	665.82	709.97	365.35
Prepaid Expenses	-	88.32	18.51	13.73	4.98
Other Current Assets	654.37	176.82	237.86	175.58	191.77
Total Current Assets	6,240	4,241	2,754	2,300	1,962
Property, Plant & Equipment	4,469	2,773	2,246	1,838	1,459
Long-Term Investments	-	3.33	3.2	2.05	1.94
Goodwill	682.4	-	-	-	-
Other Intangible Assets	67.53	2.1	3.02	3.95	-
Long-Term Deferred Tax Assets	4.95	3.25	2.28	5.44	4.74
Other Long-Term Assets	284.88	148.43	130.62	51.49	22.88
Total Assets	11,749	7,172	5,139	4,201	3,450
Accounts Payable	684.28	604.8	507.1	384.96	305.54
Accrued Expenses	-	47.85	40.71	514.57	578.16
Short-Term Debt	-	654.9	548.3	518.17	484.8
Current Portion of Long-Term Debt	1,140	302.11	97.16	104.97	70
Current Portion of Leases	7.98	6.44	7.51	2.86	2.2
Current Income Taxes Payable	9.84	27.88	1.72	20.04	9.66
Other Current Liabilities	177.51	103.59	170.11	162.72	24.83
Total Current Liabilities	2,020	1,748	1,373	1,708	1,475
Long-Term Debt	342.86	395.53	111.43	199.41	282.34
Long-Term Leases	13.37	16.55	22.99	5.42	8.28
Pension & Post-Retirement Benefits	-	2.9	3.94	-	2.12
Long-Term Deferred Tax Liabilities	94.03	63.59	58.47	51.33	48.48
Other Long-Term Liabilities	297.97	14.64	9.27	3.83	5.54
Total Liabilities	2,768	2,241	1,579	1,968	1,822
Common Stock	112.95	97.23	14.09	14.09	14.09
Additional Paid-In Capital	-	-	98.56	98.56	98.56
Retained Earnings	-	4,856	3,478	2,150	1,527
Comprehensive Income & Other	8,720	-21.85	-30.74	-30.08	-11.18
Total Common Equity	8,833	4,931	3,560	2,233	1,628
Minority Interest	147.54	-	-	-	-
Shareholders' Equity	8,981	4,931	3,560	2,233	1,628
Total Liabilities & Equity	11,749	7,172	5,139	4,201	3,450
Total Debt	1,504	1,376	787.39	830.83	847.62
Net Cash (Debt)	-357.77	-856.1	-646.37	-697.49	-632.88
Net Cash Per Share	-3.21	-7.89	-5.96	-6.43	-5.83
Filing Date Shares Outstanding	111.59	97.23	31	1.41	1.41
Total Common Shares Outstanding	111.59	97.23	31	1.41	1.41
Working Capital	4,220	2,494	1,381	591.89	486.41
Book Value Per Share	79.16	50.72	114.84	1584.59	1155.38
Tangible Book Value	8,083	4,929	3,557	2,229	1,628
Tangible Book Value Per Share	72.44	50.69	114.74	1581.79	1155.38
Land	-	133.17	132.89	131.5	68.48
Buildings	-	896.82	840.79	702.97	684.18
Machinery	-	875.05	783.77	652.02	467.49
Construction In Progress	-	882.17	446.61	259.72	81.27
Leasehold Improvements	-	30.76	-	-	-